Holen Sie sich die Stockscreener-App
1.10
1.79%
-0.02
Handel nachbörslich:
1.11
0.01
+0.91%
Schlusskurs vom Vortag:
$1.12
Offen:
$1.12
24-Stunden-Volumen:
75,644
Relative Volume:
0.36
Marktkapitalisierung:
$19.15M
Einnahmen:
$52.58M
Nettoeinkommen (Verlust:
$-3.28M
KGV:
-5.7084
EPS:
-0.1927
Netto-Cashflow:
$-2.53M
1W Leistung:
-2.65%
1M Leistung:
-2.65%
6M Leistung:
-4.35%
1J Leistung:
+6.80%
1-Tages-Spanne:
$1.10
$1.125
1-Wochen-Bereich:
$1.10
$1.15
52-Wochen-Spanne:
$0.8688
$1.6481
Iridex Corp Stock (IRIX) Company Profile
Firmenname
Iridex Corp
Sektor
Branche
Telefon
(650) 940-4700
Adresse
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.10 | 19.15M | 52.58M | -3.28M | -2.53M | -0.1927 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-11-03 | Fortgesetzt | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2016-01-26 | Eingeleitet | Singular Research | Buy |
| 2007-01-03 | Eingeleitet | First Albany | Buy |
Iridex Corp Aktie (IRIX) Neueste Nachrichten
Form 4 IRIDEX Corporation For: 8 July By Investing.com - Investing.com Nigeria
Novel Inspiration gains IRIDEX (IRIX) shares as quarterly note interest - Stock Titan
IRIDEX Corp updates retinal laser portfolio as ophthalmology demand evolves - ad-hoc-news.de
IRIDEX Corporation (IRIX) Slides Amid Light Trading, Key Support Levels in FocusArms Index - dars.gov.et
IRIX Q1 2026 Earnings: Loss Narrows Significantly as EPS Surprises to the UpsideEarnings Revision Upgrade - dars.gov.et
IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
IRIDEX Corp (IRIX) Institutional Confidence - TradingKey
IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRIDEX (IRIX) adjourns 2026 shareholder meeting, sets July 10 reconvene date - Stock Titan
IRIDEX Corp (IRIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRIDEX Corp (IRIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRIDEX Corp (IRIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRIDEX (IRIX) CFO has 2,691 shares withheld to pay taxes - Stock Titan
IRIDEX (IRIX) CEO surrenders 3,990 shares to cover tax obligations - Stock Titan
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX) - GuruFocus
Iridex CFO Romeo Dizon buys $1,110 in company stock - Investing.com UK
Iridex CFO Romeo Dizon buys $1,110 in company stock By Investing.com - Investing.com South Africa
IRIDEX (IRIX) CFO Romeo Dizon adds 975 common shares in open-market buy - Stock Titan
IRIX News | IRIDEX CORP (NASDAQ:IRIX) - ChartMill
Iridex CFO Romeo Dizon buys $1,909 in company stock By Investing.com - Investing.com Australia
Iridex CFO Romeo Dizon buys $1,909 in company stock - Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 1,675 shares in open-market stock purchase - Stock Titan
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference - The Manila Times
Iridex CFO Romeo Dizon buys $2,688 in company stock By Investing.com - Investing.com Australia
Iridex CFO Romeo Dizon buys $2,688 in company stock - Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 2,400 shares in open-market buy - Stock Titan
Iridex CFO Dizon purchases $2,899 of common stock By Investing.com - Investing.com India
Iridex CFO Dizon purchases $2,899 of common stock - Investing.com UK
IRIDEX Corp (IRIX) CFO adds 2,521 shares in open-market stock purchase - Stock Titan
IRIDEX Corp stock (US4627191006): Laser eye-care specialist after recent earnings update - Ad-hoc-news.de
Iridex CFO Romeo Dizon buys $2,808 in company stock By Investing.com - Investing.com Nigeria
Iridex CFO Romeo Dizon buys $2,808 in company stock - Investing.com
CFO of IRIDEX (NASDAQ: IRIX) purchases 2,400 company shares - Stock Titan
Iridex CFO Romeo Dizon buys $5,004 in company stock By Investing.com - Investing.com Australia
IRIDEX (IRIX) CEO Patrick Mercer delivers shares to cover tax obligations - Stock Titan
Finanzdaten der Iridex Corp-Aktie (IRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iridex Corp-Aktie (IRIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Jun 11 '26 |
Buy |
1.14 |
1,675 |
1,909 |
135,000 |
| Dizon Romeo R | Chief Financial Officer |
Jun 08 '26 |
Buy |
1.12 |
2,400 |
2,688 |
133,325 |
| Dizon Romeo R | Chief Financial Officer |
Jun 05 '26 |
Buy |
1.15 |
2,521 |
2,899 |
130,925 |
| Dizon Romeo R | Chief Financial Officer |
Jun 03 '26 |
Buy |
1.17 |
2,400 |
2,808 |
128,404 |
| Dizon Romeo R | Chief Financial Officer |
May 26 '26 |
Buy |
1.00 |
5,004 |
5,004 |
126,004 |
| Dizon Romeo R | Chief Financial Officer |
Mar 06 '26 |
Buy |
1.26 |
1,110 |
1,399 |
121,000 |
| Dizon Romeo R | Chief Financial Officer |
Feb 17 '26 |
Buy |
1.34 |
2,200 |
2,942 |
119,890 |
| Dizon Romeo R | Chief Financial Officer |
Feb 12 '26 |
Buy |
1.43 |
1,500 |
2,145 |
117,690 |
| Dizon Romeo R | Chief Financial Officer |
Feb 10 '26 |
Buy |
1.46 |
1,000 |
1,460 |
116,190 |
| Dizon Romeo R | Chief Financial Officer |
Feb 03 '26 |
Buy |
1.38 |
2,500 |
3,450 |
115,190 |
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):